Post-marketing safety assessment of epinephrine: an analysis of the US FDA adverse event reporting system
This investigation identified numerous previously unreported AE signals associated with epinephrine. Further clinical studies are necessary to substantiate these findings and elucidate the causal relationships.
Authors
- Bing Yan (ORCID: https://orcid.org/0000-0002-7970-6764)
- Yang Jiang (ORCID: https://orcid.org/0000-0002-5364-1421)
- Qing Xiao (ORCID: https://orcid.org/0000-0003-0545-934X)
Institutions
- People's Liberation Army 401 Hospital (CN)
- Qingdao Eighth People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-12-18
- DOI
- https://doi.org/10.3389/fmed.2025.1727631
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00